Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer.

[1]  D. Kuban,et al.  Biochemical and clinical significance of the posttreatment prostate‐specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone , 2006, Cancer.

[2]  Paul Schellhammer,et al.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.

[3]  T. Pickles.  Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy. , 2006, International journal of radiation oncology, biology, physics.

[4]  J. Ciezki,et al.  PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. , 2006, International journal of radiation oncology, biology, physics.

[5]  D. Kuban,et al.  Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer? , 2005, Urology.

[6]  A. Zietman,et al.  PSA bounces after neoadjuvant androgen deprivation and external beam radiation: impact on definitions of failure. , 2005, International journal of radiation oncology, biology, physics.

[7]  E. Karabulut,et al.  PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. , 2005, European urology.

[8]  E. B. Butler,et al.  Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. , 2005, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[9]  T. Fukagai,et al.  [PSA bounce phenomenon after transperineal interstitial permanent prostate brachytherapy for localized prostate cancer]. , 2004, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[10]  A. K. Levinson,et al.  Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. , 2003, The Journal of urology.

[11]  R. Stock,et al.  Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications. , 2003, International journal of radiation oncology, biology, physics.

[12]  L. Turkeri,et al.  PSA bouncing after external beam radiation for prostate cancer with or without hormonal treatment. , 2003, European urology.

[13]  F. Critz.  Time to achieve a prostate specific antigen nadir of 0.2 ng./ml. after simultaneous irradiation for prostate cancer. , 2002, The Journal of urology.

[14]  D. Kuban,et al.  Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. , 2002, The Journal of urology.

[15]  A. Renshaw,et al.  Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. , 2002, International journal of radiation oncology, biology, physics.

[16]  K. Wallner,et al.  Prostate-specific antigen spikes after permanent prostate brachytherapy. , 2002, International journal of radiation oncology, biology, physics.

[17]  E. B. Butler,et al.  Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization. , 2002, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[18]  E. B. Butler,et al.  Prostate immobilization using a rectal balloon , 2002, Journal of applied clinical medical physics.

[19]  E. B. Butler,et al.  Intensity Modulated Radiotherapy (IMRT) Decreases Treatment-Related Morbidity and Potentially Enhances Tumor Control , 2002, Cancer investigation.

[20]  E. B. Butler,et al.  Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. , 2001, International journal of radiation oncology, biology, physics.

[21]  J. Blasko,et al.  Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer. , 2000, Seminars in urologic oncology.

[22]  A. K. Levinson,et al.  Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. , 2000, Journal of Urology.

[23]  E. B. Butler,et al.  Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. , 1999, The oncologist.

[24]  C. Ling,et al.  Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[25]  Americansocietyfortherapeuticr.  Consensus statement: Guidelines for PSA following radiation therapy1 , 1997 .

[26]  T. Stamey,et al.  Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers. , 1996, The Journal of urology.

[27]  T. Stamey,et al.  Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population. , 1996, Urology.

[28]  J. Ciezki,et al.  PSA bounce predicts early success in patients with permanent iodine-125 prostate implant. , 2004, Urology.

[29]  A. Hanlon,et al.  Patterns and fate of PSA bouncing following 3D-CRT. , 2001, International journal of radiation oncology, biology, physics.